| Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor MK Tripathi, P Singh, S Sharma, TP Singh, AS Ethayathulla, P Kaur Journal of Biomolecular Structure and Dynamics 39 (15), 5668-5681, 2021 | 180 | 2021 |
| Biphenyl-3-oxo-1, 2, 4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory PN Tripathi, P Srivastava, P Sharma, MK Tripathi, A Seth, A Tripathi, ... Bioorganic Chemistry 85, 82-96, 2019 | 150 | 2019 |
| Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery MK Tripathi, A Nath, TP Singh, AS Ethayathulla, P Kaur Molecular Diversity 25, 1439-1460, 2021 | 97 | 2021 |
| Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease SKS Piyoosh Sharma, Avanish Tripathi, Prabhash Tripathi, Santosh Kumar ... European Journal of Medicinal Chemistry 167, 510-524, 2019 | 97 | 2019 |
| Green Synthesis of Silver Nanoparticles Using Leaf Extract of Common Arrowhead Houseplant and Its Anticandidal Activity M Yasir, J Singh, MK Tripathi, P Singh, R Shrivastava Pharmacognosy Magazine 13 (840), 844, 2017 | 72 | 2017 |
| Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1, 3, 4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease A Tripathi, PK Choubey, P Sharma, A Seth, PN Tripathi, MK Tripathi, ... European journal of medicinal chemistry 183, 111707, 2019 | 70 | 2019 |
| Potential inhibitors for SARS-CoV-2 and functional food components as nutritional supplement for COVID-19: a review P Singh, MK Tripathi, M Yasir, R Khare, MK Tripathi, R Shrivastava Plant Foods for Human Nutrition 75, 458-466, 2020 | 62 | 2020 |
| Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer’s disease SK Shrivastava, SK Sinha, P Srivastava, PN Tripathi, P Sharma, ... Bioorganic chemistry 82, 211-223, 2019 | 59 | 2019 |
| Fundamentals of molecular modeling in drug design MK Tripathi, S Ahmad, R Tyagi, V Dahiya, MK Yadav Computer Aided Drug Design (CADD): From ligand-based methods to structure …, 2022 | 41 | 2022 |
| Design, synthesis, and evaluation of N-benzylpyrrolidine and 1, 3, 4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer’s disease PK Choubey, A Tripathi, MK Tripathi, A Seth, SK Shrivastava Bioorganic Chemistry 111, 104922, 2021 | 37 | 2021 |
| Cholinesterase as a target for drug development in Alzheimer’s disease P Sharma, MK Tripathi, SK Shrivastava Targeting Enzymes for Pharmaceutical Development: Methods and Protocols, 257-286, 2020 | 33 | 2020 |
| Computational exploration and experimental validation to identify a dual inhibitor of cholinesterase and amyloid-beta for the treatment of Alzheimer’s disease MK Tripathi, P Sharma, A Tripathi, PN Tripathi, P Srivastava, A Seth, ... Journal of Computer-Aided Molecular Design 34, 983-1002, 2020 | 25 | 2020 |
| Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B. 1.617. 2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India P Singh, K Sharma, P Singh, A Bhargava, SS Negi, P Sharma, M Bhise, ... Microbial Pathogenesis 164, 105404, 2022 | 22 | 2022 |
| The genus Glycosmis [Rutaceae]: a comprehensive review on its phytochemical and pharmacological perspectives M Yasir, MK Tripathi, P Singh, R Shrivastava The Natural Products Journal 9 (2), 98-124, 2019 | 22 | 2019 |
| Novel 5, 6-diphenyl-1, 2, 4-triazine-3-thiol derivatives as dual COX-2/5-LOX inhibitors devoid of cardiotoxicity P Saraf, PN Tripathi, MK Tripathi, A Tripathi, H Verma, DK Waiker, ... Bioorganic Chemistry 129, 106147, 2022 | 20 | 2022 |
| Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015) BMC Genomics 17 (6), 487, 2016 | 19* | 2016 |
| Therapeutic protein-based vaccines S Ahmad, V Dahiya, A Vibhuti, RP Pandey, MK Tripathi, MK Yadav Protein-based therapeutics, 355-384, 2023 | 17 | 2023 |
| Computational intelligence in drug repurposing for COVID-19 MK Tripathi, S Sharma, TP Singh, AS Ethayathulla, P Kaur Computational Intelligence Methods in COVID-19: Surveillance, Prevention …, 2021 | 15 | 2021 |
| Insights from the molecular docking of hydrolytic products of methyl isocyanate (MIC) to inhibition of human immune proteins MK Tripathi, M Yasir, VS Gurjar, P Bose, A Dubey, R Shrivastava Interdisciplinary Sciences: Computational Life Sciences 7 (3), 287-294, 2015 | 14 | 2015 |
| Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and β-Secretase for treatment of Alzheimer's disease SK Shrivastava, AA Nivrutti, B Bhardwaj, DK Waiker, A Verma, PN Tripathi, ... Journal of Molecular Structure 1262, 132979, 2022 | 13 | 2022 |